X
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    digital validation pharma

    Digital Validation and Compliance in Pharma

    green bioprocessing pharma

    Carbon-Neutral Bioprocessing in Pharmaceuticals

    precision fermentation biotech

    Precision Fermentation and the Future of Biomanufacturing

    cell therapy biotech

    Regenerative Medicine and Cell Therapy Innovations

    smart pharma labs

    Digital Transformation of Smart Pharma R&D Labs

    AI in drug discovery

    AI in Drug Discovery Accelerates Pharma Innovation

    GLP1 therapy

    FDA Approves Novo Nordisk’s Rybelsus Oral GLP-1 Therapy

    TEZSPIRE for CRSwNP

    FDA Approves Amgen and AstraZeneca’s TEZSPIRE for CRSwNP

    Lupus Nephritis

    FDA Clears Genentech’s Gazyva for Lupus Nephritis in Adults

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    digital validation pharma

    Digital Validation and Compliance in Pharma

    green bioprocessing pharma

    Carbon-Neutral Bioprocessing in Pharmaceuticals

    precision fermentation biotech

    Precision Fermentation and the Future of Biomanufacturing

    cell therapy biotech

    Regenerative Medicine and Cell Therapy Innovations

    smart pharma labs

    Digital Transformation of Smart Pharma R&D Labs

    AI in drug discovery

    AI in Drug Discovery Accelerates Pharma Innovation

    GLP1 therapy

    FDA Approves Novo Nordisk’s Rybelsus Oral GLP-1 Therapy

    TEZSPIRE for CRSwNP

    FDA Approves Amgen and AstraZeneca’s TEZSPIRE for CRSwNP

    Lupus Nephritis

    FDA Clears Genentech’s Gazyva for Lupus Nephritis in Adults

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Health & Nutrition

Royal DSM Completes Acquisition of Specialty Dairy Solutions Provider CSK

Content Team by Content Team
7th January 2020
in Health & Nutrition, News
Royal DSM Completes Acquisition of Specialty Dairy Solutions Provider CSK

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

The collaboration between Royal DSM and CSK will enable DSM to cater to the growing dairy markets around the globe. The deal was closed for a cash consideration of about 167 million dollars.

Heerlen/The Netherlands – Royal DSM, a global science-based company in nutrition, health and sustainable living, has recently announced the completion of the acquisition of a 100 % interest in specialty dairy solutions provider Koninklijke CSK Food Enrichment (CSK) for a cash consideration of about 167 million dollars. The acquisition of CSK was first announced on November 18.

The highly complementary combination of DSM’s dairy business and CSK’s business greatly strengthens DSM’s ability to serve the needs of dairy industries worldwide, and makes the company well-placed to address the fast-growing and attractive dairy cultures markets.

Previous Post

Cergentis launches TLA technology for complete cancer gene mutation sequencing

Next Post

Merck Establishes Strategic Oncology Collaboration with Taiho and Astex

Related Posts

Avidity Biosciences
Americas

Novartis to Acquire Avidity Biosciences in $12 Billion Deal

28th October 2025
manufacturing facility
Americas

AstraZeneca Unveils Expanded Manufacturing Facility in Texas

28th October 2025
GLP1 therapy
Americas

FDA Approves Novo Nordisk’s Rybelsus Oral GLP-1 Therapy

27th October 2025
TEZSPIRE for CRSwNP
Americas

FDA Approves Amgen and AstraZeneca’s TEZSPIRE for CRSwNP

25th October 2025
Lupus Nephritis
Americas

FDA Clears Genentech’s Gazyva for Lupus Nephritis in Adults

23rd October 2025
EYDENZELT for Retinal Diseases
Americas

FDA Approves Celltrion’s EYDENZELT for Retinal Diseases

17th October 2025
Next Post
Merck Establishes Strategic Oncology Collaboration with Taiho and Astex

Merck Establishes Strategic Oncology Collaboration with Taiho and Astex

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In